1. |
中华医学会眼科学会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2014年)[J]. 中华眼科杂志, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.Ocular Fundus Group of Chinese Medical Association Ophthalmology Society. Guidelines for the clinical diagnosis and treatment of diabetic retinopathy in China(2014)[J]. Chin J Ophthalmol, 2014, 50(11): 851-865. DOI: 10.3760/cma.j.issn.0412-4081.2014.11.014.
|
2. |
Kohno R, Hata Y, Mochizuki Y, et al. Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection[J]. Am J Ophthalmol, 2010, 150(2): 223-229. DOI: 10.1016/j.ajo.2010.03.016.
|
3. |
Jiang T, Gu J, Zhang P, et al. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study[J/OL]. BMC Ophthalmol, 2020, 20(1): 43[2020-02-03]. https://pubmed.ncbi.nlm.nih.gov/32013913/. DOI: 10.1186/s12886-020-1321-9.
|
4. |
El-Sabagh HA, Abdelghaffar W, Labib AM, et al. Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications[J]. Ophthalmology, 2011, 118(4): 636-641. DOI: 10.1016/j.ophtha.2010.08.038.
|
5. |
Van Geest RJ, Lesnik-Oberstein SY, Tan HS, et al. A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy[J]. Br J Ophthalmol, 2012, 96(4): 587-590. DOI: 10.1136/bjophthalmol-2011-301005.
|
6. |
Makita S, Hong Y, Yamanari M, et al. Optical coherence angiography[J]. Opt Express, 2006, 14(17): 7821-7840. DOI: 10.1364/oe.14.007821.
|
7. |
Hwang TS, Jia Y, Gao SS, et al. Optical coherence tomography angiography features of diabetic retinopathy[J]. Retina, 2015, 35(11): 2371-2376. DOI: 10.1097/IAE.0000000000000716.
|
8. |
Russell JF, Flynn HW Jr, Sridhar J, et al. Distribution of diabetic neovascularization on ultra-widefield fluorescein angiography and on simulated widefield OCT angiography[J]. Am J Ophthalmol, 2019, 207: 110-120. DOI: 10.1016/j.ajo.2019.05.031.
|
9. |
Pan J, Chen D, Yang X, et al. Characteristics of neovascularization in early stages of proliferative diabetic retinopathy by optical coherence tomography angiography[J]. Am J Ophthalmol, 2018, 192: 146-156. DOI: 10.1016/j.ajo.2018.05.018.
|
10. |
Hahn P, Migacz J, O'Connell R, et al. Unprocessed real-time imaging of vitreoretinal surgical maneuvers using a microscope-integrated spectral-domain optical coherence tomography system[J]. Graefe’s Arch Clin Exp Ophthalmol, 2013, 251(1): 213-220. DOI: 10.1007/s00417-012-2052-2.
|
11. |
Ehlers JP, Modi YS, Pecen PE, et al. The discover study 3-year results: feasibility and usefulness of microscope-integrated intraoperative OCT during ophthalmic surgery[J]. Ophthalmology, 2018, 125(7): 1014-1027. DOI: 10.1016/j.ophtha.2017.12.037.
|
12. |
Ehlers JP, Griffith JF, Srivastava SK. Intraoperative optical coherence tomography during vitreoretinal surgery for dense vitreous hemorrhage in the pioneer study[J]. Retina, 2015, 35(12): 2537-2542. DOI: 10.1097/IAE.0000000000000660.
|
13. |
Ehlers JP, Goshe J, Dupps WJ, et al. Determination of feasibility and utility of microscope-integrated optical coherence tomography during ophthalmic surgery: the discover study rescan results[J]. JAMA Ophthalmol, 2015, 133(10): 1124-1132. DOI: 10.1001/jamaophthalmol.2015.2376.
|
14. |
Carrasco-Zevallos OM, Keller B, Viehland C, et al. Optical coherence tomography for retinal surgery: perioperative analysis to real-time four-dimensional image-guided surgery[J]. Invest Ophthalmol Vis Sci, 2016, 57(9): OCT37-50. DOI: 10.1167/iovs.16-19277.
|
15. |
Gabr H, Chen X, Zevallos-Carrasco OM, et al. Visualization from intraoperative swept-source microscope-integrated optical coherence tomography in vitrectomy for complications of proliferative diabetic retinopathy[J]. Retina, 2018, 38 Suppl 1: S110-120. DOI: 10.1097/IAE.0000000000002021.
|
16. |
González-Saldivar G, Chow DR. Optimizing visual performance with digitally assisted vitreoretinal surgery[J]. Ophthalmic Surg Lasers Imaging Retina, 2020, 51(4): S15-S21. DOI: 10.3928/23258160-20200401-02.
|
17. |
Zhang T, Tang W, Xu G. Comparative analysis of three-dimensional heads-up vitrectomy and traditional microscopic vitrectomy for vitreoretinal diseases[J]. Curr Eye Res, 2019, 44(10): 1080-1086. DOI: 10.1080/02713683.2019.1612443.
|
18. |
Adam MK, Thornton S, Regillo CD, et al. Minimal endoillumination levels and display luminous emittance during three-dimensional heads-up vitreoretinal surgery[J]. Retina, 2017, 37(9): 1746-1749. DOI: 10.1097/IAE.0000000000001420.
|
19. |
Kumar A, Hasan N, Kakkar P, et al. Comparison of clinical outcomes between "heads-up" 3D viewing system and conventional microscope in macular hole surgeries: a pilot study[J]. Indian J Ophthalmol, 2018, 66(12): 1816-1819. DOI: 10.4103/ijo.IJO_59_18.
|
20. |
Yata K, Fujiwara T, Yamamoto A, et al. Diabetes as risk factor of cataract: differentiation by retroillumination photography and image analysis[J]. Ophthalmic Res, 1990, 22 Suppl 1: S78-80. DOI: 10.1159/000267071.
|
21. |
Smiddy WE, Feuer W. Incidence of cataract extraction after diabetic vitrectomy[J]. Retina, 2004, 24(4): 574-581. DOI: 10.1097/00006982-200408000-00011.
|
22. |
Holekamp NM, Shui YB, Beebe D. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract[J]. Am J Ophthalmol, 2006, 141(6): 1027-1032. DOI: 10.1016/j.ajo.2006.01.016.
|
23. |
中华医学会眼科学分会白内障及人工晶状体学组. 中国糖尿病患者白内障围手术期管理策略专家共识(2020年)[J]. 中华眼科杂志, 2020, 56(5): 337-342. DOI: 10.3760/cma.j.cn112142-20191106-00559.Cataract and Intraocular Lens Group of the Ophthalmology Branch of the Chinese Medical Association. Expert consensus on perioperative management strategies for cataract in diabetic patients in China (2020)[J]. Chin J Ophthalmol, 2020, 56(5): 337-342. DOI: 10.3760/cma.j.cn112142-20191106-00559.
|
24. |
Silva PS, Diala PA, Hamam RN, et al. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes[J]. Retina, 2014, 34(10): 1960-1968. DOI: 10.1097/IAE.0000000000000171.
|
25. |
Ljubimov AV. Diabetic complications in the cornea[J]. Vision Res, 2017, 139: 138-152. DOI: 10.1016/j.visres.2017.03.002.
|
26. |
中华医学会糖尿病学分会视网膜病变学组. 糖尿病视网膜病变防治专家共识[J]. 中华糖尿病杂志, 2018, 10(4): 241-247. DOI: 10.3760/cma.j.issn.1674-5809.2018.04.001.Retinopathy Group of Diabetes Branch of Chinese Medical Association. Expert consensus on prevention and treatment of diabetic retinopathy[J]. Chin J Diabetes Mellitus, 2018, 10(4): 241-247. DOI: 10.3760/cma.j.issn.1674-5809.2018.04.001.
|